Introduction
Community-acquired pneumonia (CAP) is one of the main causes of mortality in children aged less than 5 years, responsible for ~19% of all deaths worldwide. 1 Antibiotic therapy is often empirically initiated, based on the epidemiological knowledge of the main bacterial agents, according to the age-group and clinical severity. 2 Although there was a decrease in all-cause mortality in children in the decade 2000-2010, including mortality caused by pneumonia, it has been estimated that submit your manuscript | www.dovepress.com
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Fonseca lima et al in 2011, CAP accounted for more than 1 million deaths among children, with ~80% of these deaths occurring in children less than 2 years of age. 1 According to the Bulletin of the World Health Organization (WHO), Brazil is one of the 15 countries with the highest incidence of CAP, with 0.11 episodes/child/year in children less than 5 years of age, which corresponds to 1.8 million cases/year. 2 The World Health Organization's definition for CAP and classification of gravity in children are done according to the symptoms and signs presented. 3 Central cyanosis, severe difficulty for breathing, and/or inability to drink suggest very severe pneumonia. 3, 4 The rational choice of empiric antibiotic therapy, essential for clinicians to provide effective care, is based on the etiologic knowledge of CAP, evidence of scientific studies, and consensus of experts. Nowadays, Streptococcus pneumoniae is the main causative agent of bacterial CAP and accounts for one-third of the 5 million deaths due to pneumonia that occur each year in developing countries. 5, 6 Young children, aged less than 2 months, are a special group with regard to CAP etiology; there is a predominance of infection by gram-negative bacteria, beta-hemolytic streptococci, and Staphylococcus aureus in this age-group. 5, 7 The WHO and other international scientific societies, such as the Infectious Disease Society of America, British Thoracic Society, and Latin American Society of Pediatric Infectious Diseases, have established guidelines for the management of CAP in children. The Brazilian Society of Pediatrics (SBP) has also made its recommendations, and the Ministry of Health of Brazil has endorsed the proposal of the WHO. [8] [9] [10] [11] [12] Our hospital, a Brazilian reference for pediatric care, has ratified those guidelines for antibiotic therapy for pneumonia and ampicillin or crystalline penicillin are the drugs of choice for the initial treatment of children hospitalized with uncomplicated CAP. 13, 14 Adequate compliance with the protocols, based on guidelines in the management of CAP, has been associated with an increase in the use of narrow-spectrum antibiotics and improved medical practices. 15 The assessment of compliance with guidelines in pediatric health care services over a 3-year period showed a 44% increase in the prescription of ampicillin and a decrease from 56% to 28% in the use of ceftriaxone. During this same period, there was no increase in the length of stay in hospital or lethality with this narrow-spectrum antibiotic. 16 The guidelines on CAP treatment are important to rationalize the use of antibiotics and prevent the selection of multidrug-resistant bacteria. Since 2007, the Infectious Diseases Society of America has formally recommended the development of programs for the management of antimicrobials improving the surveillance of antibiotic use in health care institutions. 16 In 2011, WHO established a policy package to combat antimicrobial resistance where regulate and promote rational use of medicines and ensure proper patient care is one of the cornerstones of this policy but emphasized in 2014 that the resistance to common bacteria has reached alarming levels in many parts of the world. 17, 18 Studies in Brazil have shown that in most cases there is no standardized protocol for the management of acute respiratory infections, which suggests that the quality of care for a child with acute respiratory infection can be improved through an increase in training and supervision of health care professionals, raising their awareness of the abusive and negligent use of antibiotics. [19] [20] [21] Studies that assess the prescription of antibiotics within the health care service networks are useful to detect preventable inadequacies in the care of children with pneumonia.
1,22
Methods
This was a cross-sectional study with secondary data involving children aged 1-60 months hospitalized for pneumonia between October 2010 and September 2013 in the wards and pediatric intensive care unit of Instituto de Medicina Integral Professor Fernando Figueira (IMIP). IMIP is the main reference hospital for pediatric inpatients in the city of Recife (northeast Brazil) and exclusively attends to the National Health System (SUS) users.
Sociodemographic, clinical variables, and variables related to the adequacy of antibiotic prescription in childhood CAP were analyzed.
The diagnosis of pneumonia was based on the clinical and radiological criteria established by the WHO and Brazilian Guidelines on Childhood Community-Acquired Pneumonia, 2007. 3, 4 Until 2013, the WHO classified pneumonia in children who present with cough and difficulty breathing accompanied by fever as follows: 1) pneumonia: fast breathing ($60 breaths per minute in children less than 2 months of age, $50 breaths in children aged between 2 months and 1 year, and $40 breaths in children between 1 and 4 years of age) and the presence of fine crackles on lung auscultation; 2) severe pneumonia: subcostal retraction or stridor in addition to criteria established for pneumonia; and 3) very severe pneumonia: inability to drink, intense difficulty in breathing (eg, apnea or involuntary head movements), and central cyanosis in addition to the criteria established for severe pneumonia. 3, 4, 8 Image assessment was performed by two independent radiologists according to the standardization proposed by the WHO for epidemiological studies, including the presence of 
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Prescription of antibiotics in children with community-acquired pneumonia interstitial infiltrate as an indicator of pneumonia. 23 Patients who did not present the clinical or radiological criteria for the diagnosis of pneumonia proposed by the WHO or had concomitant heart disease, nephropathy, neuropathy, hemoglobinopathy, hepatopathy, immunodeficiency, cystic fibrosis, and congenital lung malformations were excluded. Patients with hospital-acquired pneumonia were also excluded.
The sociodemographic variables included age, sex, and family income relative to the minimum wage (the lowest remuneration that Brazilian employers may legally pay to workers) and the mother's level of education defined by years of schooling.
Guidelines for the management of CAP in children recommend age-specific antibiotic therapy regimens; so, we divided the sample into two age-groups as reported usually in the guidelines: children aged less than 2 months and those aged 2-60 months but we also grouped in younger than 1 year. 4, 8 Among the clinical variables studied were low birth weight (,2,500 g) and child's nutritional status at hospital admission according to weight-for-age WHO Child Growth Standards (2006) based on z score as adequate (-2, z score ,+2), moderately malnourished (-3, z score ,-2), and severely malnourished (z score ,-3).
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The adherence to guidelines focused on first antibiotic choice and prescription modality, duration of antibiotic therapy, and antibiotic choice in case of treatment modification. In severe pneumonia, the use of either a combination of ampicillin and aminoglycoside or a third-generation cephalosporin alone was considered adequate for children less than 2 months old, and the use of ampicillin or crystalline penicillin was deemed adequate as the first therapeutic choice for children more than 2 months of age. 3, 4, 8 In cases of very severe pneumonia, the WHO recommends the use of a combination of parenteral ampicillin (or penicillin) with gentamicin or the use of ceftriaxone alone, whereas the SBP suggests the use of oxacillin combined with chloramphenicol or ceftriaxone given alone. In the present study, both the regimens were considered adequate for the treatment of very severe CAP. In the presence of parapneumonic pleural effusion, the recommended regimens were ampicillin or penicillin or the combination of oxacillin or cephalothin with chloramphenicol. 3, 4, 8 Different treatment regimens from those described were considered inadequate. Changes in antibiotic use during hospitalization were also recorded to determine the antibiotic choice in case of treatment modification.
Outcome measurements were analyzed as need of oxygen therapy, development of complications (pleural effusion), length of stay in hospital, and final outcome (discharge or death).
Data were compiled and analyzed using the MS Excel and Epi Info software version 7.0 (Centers for Disease Control and Prevention [CDC], Atlanta, GA, USA). The Statistical Package for Social Sciences software program, version 20.0 (IBM Corporation, Armonk, NY, USA), was used throughout the statistical analysis. Frequency distribution was calculated, and the prevalence ratio for the adequacy of empiric antibiotic was estimated using the chi-square test or Fisher's exact test as appropriate. Variables associated at a level of P#0.25 in the bivariate analysis were then included in a multivariable model. A multivariable logistic regression was conducted in accordance with the backward stepwise procedure, and the final model included variables significant at the 5% level.
This study was approved by the Research Ethics Committee of IMIP (number 3863-13). Written informed consent was obtained from the parents or guardians of all participants.
Results
In this study, 51.77% of the 452 enrolled children were boys; 187 (41.37%) were younger than 1 year including 39 (8.63%) younger than 2 months. Frequency distributions of variables are shown in Table 1 .
Of the 452 patients, 385 (85.18%) were classified as having severe or very severe pneumonia. Table 2 shows some 
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Fonseca lima et al features of the patients' clinical evolution. The length of stay at hospital ranged from 1 to 30 days, and approximately half of the children (50.55%) were hospitalized for less than 7 days. Supportive treatment with oxygen was necessary for 219 (48.45%) of them, and 118 (26.11%) had physical signs and radiological diagnosis of pleural effusion. There were seven deaths, and the mortality rate was 1.55%.
The treatment was classified as adequate in 334 patients (73.89%). Ampicillin was the most used antibiotic in patients hospitalized for pneumonia (62.17%), followed by ampicillin combined with gentamicin (7.96%). Others empiric antibiotic therapies are shown in Table 3 .
The antibiotic was changed during hospitalization in 29.6% of the patients; ampicillin was replaced by a combination of oxacillin with chloramphenicol. There was no difference in the adequacy of antibiotic therapy according pneumonia severity.
In the bivariate analysis (Table 4) , the inadequacy of empiric antibiotic therapy observed in patients younger than 12 months was higher but without statistical significance (P=0.10), and ~30% of the patients who underwent oxygen therapy received a empiric regimen that was deemed inadequate, in contrast to only 22% of the patients (P=0.05).
In the multivariate analysis (Table 5) , only pleural effusion remained in the model, increasing the possibility of the use of antibiotics as inappropriate (odds ratio =8.89).
Discussion
Hospital treatment and antimicrobial drug use are indicated in cases of severe and very severe pneumonia. In the present study, 85.18% of the cases were classified as having severe or very severe pneumonia, and the indication for hospitalization, as proposed in the WHO and SBP guidelines, was deemed 
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Prescription of antibiotics in children with community-acquired pneumonia adequate. The empiric antimicrobial therapy in 73.89% of them was also adequate. 3, 4 The hospital where the study was conducted is considered a Brazilian reference in pediatric health care and as a teaching hospital has its own protocols based on the national and international recommendations, which could explain the good results obtained. However, when the adequacy of antibiotic use was related to the severity of the case, the initial regimen was inadequate in approximately half of the patients with very severe pneumonia. This result confirms that even in reference centers, adherence to the protocol is not yet completely satisfactory.
Although pneumonia is an acute disease, it usually progresses to a favorable outcome, and on average, its treatment requires 7 to 10 days. Approximately 50% of the patients in the present study were hospitalized for up to 7 days and were prescribed oral antibiotics to continue the regimen at home. Studies that evaluate the mean length of stay in hospital have shown it to be 7.5 days. 25 In the present study, ampicillin was prescribed as the first choice of treatment in ~62.17% of the patients. The application of the guidelines for the rationalization of antibiotic use is essential in clinical practice. A study that followed 1,033 patients hospitalized in the 12 months before the publication of a guideline aiming to rationalize antibiotic use showed that ceftriaxone was the most prescribed antibiotic (72%), followed by ampicillin (13%). A subsequent assessment showed a change in pattern, with ampicillin being the first choice in 63% of the patients, a result that is similar to that obtained in the present study. 26 Malnutrition is associated with deficient immune response, infections, and unfavorable outcomes. Although there has been a clear improvement in the nutritional status of Brazilian children in recent years, malnutrition is one of the seven most important factors associated with severe/ very severe childhood pneumonia. [27] [28] [29] Being malnourished at hospital admission (weight-for-age ,-2 z score) was not associated with inadequate empiric antibiotic therapy. This result could be explained by the fact that IMIP has a protocol for the management of malnourished patients with an infectious condition. 30 Although hypoxemia had not remained as a risk factor for the inappropriate use of antibiotics, in recent years, it has been recognized as an important predictor of severe pneumonia and mortality. 31 The hypoxemia may be not clinically evident, and this sign could be underestimated in our study.
Pulse oximetry is now referred to as the "fifth vital sign" in adults and children, as the appropriate measure is closely related to the partial pressure of oxygen in arterial blood. 10 Despite the decline of CAP in countries that have introduced conjugate vaccines, paradoxically an increased incidence of complicated pneumonia, characterized by the presence of parapneumonic effusion, empyema, pneumatocele, pyopneumothorax, or necrotizing pneumonia and the association with sepsis, has been observed in recent years. The identification of complicated pneumonia might be more efficient to assess the prognosis than using the WHO classification of gravity. [32] [33] [34] The presence of complications is one of the causes of the failure of childhood CAP treatment, with pleural effusion being the most frequent. In a study with a historical cohort of children hospitalized with pneumonia, the rate of complications was 30.7%, and of these, 98% were pleural effusions. 35 In the present study, 26.11% of the patients presented with pneumonia complicated by pleural effusion. The treatment of pneumonia complicated by drained pleural effusion with a combination of cephalothin/oxacillin and chloramphenicol was considered the adequate regimen. There were significant differences in adequate therapy among those without and with pleural effusion, and this remained in our multivariate analysis demonstrating that these patients need special attention probably due to higher morbidity with the inappropriate use of antibiotics. We must then go further in the investigation about the clinical outcome in these children according to the antibiotic use and may be propose a new approach for this specific group.
The burden of CAP, particularly in developing countries, leads to the need for a constant search for effective strategies for the control and adequate management of the disease. Moreover, the prevalence of infections caused by resistant bacteria has increased in recent years, making this issue one of the most relevant topics in pediatric clinical practice. Despite the various systematic reviews and guidelines on the subject, adherence to the recommendations still needs to be improved.
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